Insulin downregulates the expression of the Ca2+-activated nonselective cation channel TRPM5 in pancreatic islets

Barbara Colsoul1, Griet Jacobs, Koenraad Philippaert

  • 1Laboratory of Ion Channel Research, KU Leuven, Herestraat 49, bus 802, Leuven, 3000, Belgium.

Insights

Transient Receptor Potential Melastatin 5 (TRPM5) channel expression is reduced in type 2 diabetes models. Increased insulin levels downregulate TRPM5, impacting glucose homeostasis and insulin release.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Physiology

Background:

  • Transient Receptor Potential Melastatin 5 (TRPM5) cation channel is crucial for glucose-induced insulin release and homeostasis.
  • Dysregulation of TRPM5 may contribute to the pathophysiology of type 2 diabetes.

Purpose of the Study:

  • To investigate the expression and function of Trpm5 in pancreatic islets of mouse models for type 2 diabetes.
  • To explore the relationship between leptin, insulin, and Trpm5 expression in diabetes.

Main Methods:

  • Gene expression analysis of Trpm5 mRNA in pancreatic islets.
  • Assessment of glucose-induced Ca(2+) oscillations in islets.
  • Leptin treatment in ob/ob mice and insulin treatment in MIN6 cells.

Main Results:

  • Trpm5 mRNA levels were significantly reduced in db/db and ob/ob mice.
  • Glucose-induced Ca(2+) oscillations in db/db and ob/ob islets resembled Trpm5 (-/-) islets.
  • Leptin treatment upregulated Trpm5 in ob/ob mice, but insulin downregulated TRPM5 in MIN6 cells.

Conclusions:

  • Reduced Trpm5 expression is associated with type 2 diabetes in mice.
  • Elevated plasma insulin levels downregulate TRPM5 expression in pancreatic islets.
  • TRPM5 plays a role in the altered islet function observed in type 2 diabetes.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36